Tandem Choice Program

References

1. Kovatchev BP, Singh H, Mueller L, Gonder-Frederick LA. Biobehavioral Changes Following Transition to Automated Insulin Delivery: A Large Real-life Database Analysis. Diabetes Care. 2022;45(11):2636-2643.

2. Pinsker JE, Singh H, Graham R, et al. Significant Reductions in Adverse Events and Hospitalizations with Control-IQ Technology in Pediatric Users with Type 1 Diabetes: Results from the CLIO Study. Poster presented at International Society for Pediatric and Adolescent Diabetes 47th Annual Conference; October 13-1S, 2021; Virtual.

3. Breton MD, Kovatchev BP. One year real-world use of the Control-IQ advanced hybrid closed-loop technology. Diabetes Technol Ther. 2021;23(9):601-608. doi: 10.1089/dia.2021.0097.

4. Kudva YC, Laffel LM, Brown SA, et al. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial. Diabetes Technol Ther. 2021;23(10):673-683. doi: 10.1089/dia.2021.0089.

5. dQ&A US Diabetes Connections Patient Panel Report; Net Promoter Score; Jan. 2019-Sept. 2023: P.49, Sept. 2023.

Program Terms and Conditions

Participants in the Tandem Choice Program (“Program”) must be able to cover the costs of supplies for the duration of their original pump’s existing warranty (“Program Period”), either through their current insurance plan or other standard payment options. Purchase of supplies directly from Tandem is not required; in most cases participants can continue to purchase supplies from their current distributor. Insurance verification, including confirmation of duration of the participant’s current pump warranty, and a prescription will be required to start the Program. Payment plans are not available in connection with the Program.

Program terms and conditions are subject to change at any time, without notice. Limitations apply. A valid prescription is required. This offer is not available for people under 6 years of age. Offer is not valid for: members of a Kaiser Permanente Health Plan; members of health plans or insurance contracts that prohibit this Program; residents of any state where prohibited by law; persons residing outside the United States and Puerto Rico or where otherwise prohibited; and customers on a Tandem payment plan.

This offer will expire February 29, 2024. All pump switches made under the Program must be completed before December 31, 2024. Program participants are limited to one switch per warranty period.

Customers Switching to Tandem from a Non-Tandem Pump

The Program is available for non-Tandem pump users with at least six months remaining on the warranty of their current pump to switch under the Program for a program fee of $999. Offer not available to individuals with in-warranty pumps who are eligible for a new pump through their insurance plan or for any person insured or subject to reimbursement in any party by Medicaid, Medicare, Tricare, or any other federal or state health programs. The remaining warranty duration of participant’s existing pump will apply to the Tandem pump received through the Program. Warranty support for the Tandem pump during the Program Period shall be in accordance with the warranty accompanying the Tandem Pump.

Customers switching to a Tandem pump from a non-Tandem, in warranty pump will have 90 days from receipt of the Tandem pump to determine if they prefer the Tandem pump or their current, non-Tandem pump. Customers who decide to return the Tandem pump within the 90-day return period are eligible for a refund of the Program fee minus a $199 administrative fee. Customers who decide to keep the Tandem pump must return the Tandem pump at the expiration of their non-Tandem pump’s warranty.  Failure to return the Tandem pump within 90 days of the warranty expiration will result in a charge for the full cash price of the Tandem pump, less the prior one-time payment of the Program fee.

Customers Switching from the t:slim X2 Insulin Pump to the Tandem Mobi System

The Program is available to Tandem pump customers with at least twelve months remaining on the warranty of their current pump at the time of switch under the Program. Offer not available to individuals with in-warranty pumps who are eligible for a new pump through their insurance plan. The remaining warranty duration of participant’s existing pump will apply to the Tandem pump received through the Program. Warranty support for the Tandem pump during the Program Period shall be in accordance with the warranty accompanying the Tandem Pump.

If you are switching from the t:slim X2 insulin pump to the Tandem Mobi, you will have 90 days from receipt of the Tandem Mobi insulin pump to determine if you prefer the new Tandem Mobi or if you prefer your current t:slim X2 insulin pump and to return the non-selected pump. Failure to return the non-selected pump within ninety (90) days following the receipt of the Tandem Mobi will result in a charge for the full cash price of the Tandem Mobi insulin pump, less the prior one-time payment of the Program fee.

If you purchased a t:slim X2 insulin pump prior to July 1, 2023, the program fee is $999. If you purchased a t:slim X2 insulin pump during the Limited Time Offer between July 1, 2023 and December 31, 2023, the program fee is $199. If you purchased a t:slim X2 insulin pump between January 1, 2024 and February 29, 2024, the program fee is $999.

If you purchased the t:slim X2 insulin pump prior to July 1, 2023, or after December 31, 2023, have switched to Tandem Mobi, and wish to return the Tandem Mobi within the 90-day return period, you are eligible for a refund of the Program fee minus a $199 administrative fee. If you purchased the t:slim X2 insulin pump between July 1, 2023 and December 31, 2023, have switched to Tandem Mobi, and wish to return the Tandem Mobi within the 90-day return period, you will not be eligible for a refund of the $199 Program fee.